uniQure N.V (NASDAQ: QURE) kicked off on Monday, down -49.34% from the previous trading day, before settling in for the closing price of $67.69. Over the past 52 weeks, QURE has traded in a range of $5.35-$71.50.
Healthcare Sector giant saw their annual sales slid by -9.66% over the last five years. While this was happening, its average annual earnings per share was recorded 33.63%. With a float of $54.63 million, this company’s outstanding shares have now reached $54.87 million.
uniQure N.V (QURE) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of uniQure N.V is 11.32%, while institutional ownership is 85.43%. The most recent insider transaction that took place on Sep 24 ’25, was worth 9,382,473. In this transaction CEO, Managing Director of this company sold 226,316 shares at a rate of $41.46, taking the stock ownership to the 651,454 shares. Before that another transaction happened on Sep 26 ’25, when Company’s Chief Financial Officer sold 15,000 for $55.00, making the entire transaction worth $825,000. This insider now owns 217,730 shares in total.
uniQure N.V (QURE) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.84 earnings per share (EPS), higher than consensus estimate (set at -0.93) by 0.09. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.66 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 33.63% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 54.36% during the next five years compared to -9.66% drop over the previous five years of trading.
uniQure N.V (NASDAQ: QURE) Trading Performance Indicators
Take a look at uniQure N.V’s (QURE) current performance indicators. Last quarter, stock had a quick ratio of 9.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 147.31.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.92, a number that is poised to hit -0.90 in the next quarter and is forecasted to reach -2.99 in one year’s time.
Technical Analysis of uniQure N.V (QURE)
Analysing the last 5-days average volume posted by the [uniQure N.V, QURE], we can find that recorded value of 7.42 million was better than the volume posted last year of 2.12 million. As of the previous 9 days, the stock’s Stochastic %D was 56.04%.
During the past 100 days, uniQure N.V’s (QURE) raw stochastic average was set at 37.11%, which indicates a significant increase from 23.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 4.61 in the past 14 days, which was higher than the 2.08 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $41.10, while its 200-day Moving Average is $20.64. Now, the first resistance to watch is $39.37. This is followed by the second major resistance level at $44.45. The third major resistance level sits at $52.71. If the price goes on to break the first support level at $26.03, it is likely to go to the next support level at $17.77. Should the price break the second support level, the third support level stands at $12.69.
uniQure N.V (NASDAQ: QURE) Key Stats
The company with the Market Capitalisation of 2.11 billion has total of 54,867K Shares Outstanding. Its annual sales at the moment are 27,120 K in contrast with the sum of -239,560 K annual income. Company’s last quarter sales were recorded 5,260 K and last quarter income was -37,720 K.
